Vaccination in Individuals with Multiple Sclerosis--Part I/Multipl Skleroz Tanili Bireylerde Asilama--Bolum I

Multiple sclerosis (MS) is an autoimmune and demyelinating disease of the central nervous system. It is a chronic disease, and in the evaluation of all other health and vital processes, decisions should be made by considering the disease process and the drugs used by the patient. Since vaccination c...

Full description

Saved in:
Bibliographic Details
Published inTürk nöroloji dergisi Vol. 29; no. 1; p. 2
Main Authors Cinar, Bilge Piri, Tuncer, Asli, Bilge, Nuray, Bunul, Sena Destan, Gozubatik-Celik, Rabia Gokcen, Genc, Gencer, Karaman, Bedriye, Kilic, Ahmet Kasim, Sariteke, Alp, Tiftikcioglu, Bedile Irem, Tunc, Abdulkadir, Uncu, Gulgun, Yavas, Irfan, Yetkin, Mehmet Fatih, Efendi, Husnu, Siva, Aksel
Format Journal Article
LanguageEnglish
Published Galenos Yayinevi Tic. Ltd 01.03.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Multiple sclerosis (MS) is an autoimmune and demyelinating disease of the central nervous system. It is a chronic disease, and in the evaluation of all other health and vital processes, decisions should be made by considering the disease process and the drugs used by the patient. Since vaccination can be performed at every stage of life, from childhood to adulthood, immune system activity, except where it is characteristic of the vaccine, should be reviewed in patients with MS. In this review, the applications of different vaccines in individuals with MS are discussed in two separate sections. Keywords: Multiple sclerosis, vaccination, safety Multipl skleroz (MS) merkezi sinir sisteminin otoimmun ve demiyelinizan hastaligidir. Kronik bir hastalik olup bireye ait tum diger saglik ve yasamsal sureclerin degerlendirilmesinde hastalik sureci, hastanin kullandigi ilaclari goz onune alarak karar vermek gereklidir. Asilama, cocukluktan yetiskinlige yasamin her doneminde uygulanabildigi icin MS tanili bireylerde de her bir asinin ozelligi disinda hastanin immun sistem etkinligi mutlaka gozden gecirilmelidir. Bu derlemede MS tanili bireylerde farkli asilarin uygulamalari tartisilacak olup, farkli iki bolum halinde yayinlanacaktir. Anahtar Kelimeler: Multipl skleroz, asilama, guvenlik
ISSN:1301-062X
1309-2545
DOI:10.4274/tnd.2023.62592